Zoster vaccine
Tracked across 2 events · 26 articles · First seen Jun 15, 2026 · Last active Aug 29, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Zoster vaccine is the recombinant zoster vaccine that was studied and found to be associated with a lower risk of dementia. This research highlights a potential new benefit for the vaccine, which could increase its market demand and positive perception for its maker, GSK plc.
Jun 15, 2026 · 6 articles
Tech
A study led by Maxime Taquet at the University of Oxford, published in Nature Medicine, analyzed health records of over 70,000 US adults aged 60 and older from the TriNetX database. The study leveraged the…
Impact: The older vaccine used as comparator; its replacement by Zoster vaccine enabled the natural experiment.
Aug 26, 2026 · 20 articles
ERGEN INTELLIGENCE
Track Zoster vaccine live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard